Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-010803
Filing Date
2023-02-17
Accepted
2023-02-17 17:26:39
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5/A SUBMISSION doc5a.html 5/A  
1 FORM 5/A SUBMISSION doc5a.xml 5/A 4853
  Complete submission text file 0001209191-23-010803.txt   6195
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Wettig Thane (Reporting) CIK: 0001815638 (see all company filings)

Type: 5/A | Act: 34 | File No.: 001-36740 | Film No.: 23644156